263 related articles for article (PubMed ID: 28152123)
1. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Ertz-Archambault N; Kosiorek H; Taylor GE; Kelemen K; Dueck A; Castro J; Marino R; Gauthier S; Finn L; Sproat LZ; Palmer J; Mesa RA; Al-Kali A; Foran J; Tibes R
JAMA Oncol; 2017 Jul; 3(7):936-943. PubMed ID: 28152123
[TBL] [Abstract][Full Text] [Related]
2. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
[TBL] [Abstract][Full Text] [Related]
3. Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.
Mamtani R; Clark AS; Scott FI; Brensinger CM; Boursi B; Chen L; Xie F; Yun H; Osterman MT; Curtis JR; Lewis JD
Arthritis Rheumatol; 2016 Oct; 68(10):2403-11. PubMed ID: 27159030
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
Bernatsky S; Ramsey-Goldman R; Joseph L; Boivin JF; Costenbader KH; Urowitz MB; Gladman DD; Fortin PR; Nived O; Petri MA; Jacobsen S; Manzi S; Ginzler EM; Isenberg D; Rahman A; Gordon C; Ruiz-Irastorza G; Yelin E; Bae SC; Wallace DJ; Peschken CA; Dooley MA; Edworthy SM; Aranow C; Kamen DL; Romero-Diaz J; Askanase A; Witte T; Barr SG; Criswell LA; Sturfelt GK; Blanco I; Feldman CH; Dreyer L; Patel NM; St Pierre Y; Clarke AE
Ann Rheum Dis; 2014 Jan; 73(1):138-42. PubMed ID: 23303389
[TBL] [Abstract][Full Text] [Related]
5. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
[TBL] [Abstract][Full Text] [Related]
6. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
[TBL] [Abstract][Full Text] [Related]
7. Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States.
Kota V; Ogbonnaya A; Farrelly E; Schroader BK; Raju A; Kristo F; Dalal M
Adv Ther; 2023 Apr; 40(4):1655-1669. PubMed ID: 36422807
[TBL] [Abstract][Full Text] [Related]
8. Association of patient copayment and medication adherence in systemic lupus erythematosus.
Lomanto Silva R; Swabe GM; Sattui SE; Magnani JW
Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37852670
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
[TBL] [Abstract][Full Text] [Related]
10. Association between meat, fish, and fatty acid intake and incidence of acute myeloid leukemia and myelodysplastic syndrome: the Japan Public Health Center-based Prospective Study.
Shimomura Y; Sobue T; Zha L; Kitamura T; Iwasaki M; Inoue M; Yamaji T; Tsugane S; Sawada N
Environ Health Prev Med; 2023; 28():19. PubMed ID: 36878605
[TBL] [Abstract][Full Text] [Related]
11. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.
Linabery AM; Roesler MA; Richardson M; Warlick ED; Nguyen PL; Cioc AM; Poynter JN
Cancer Epidemiol; 2022 Feb; 76():102090. PubMed ID: 34995873
[TBL] [Abstract][Full Text] [Related]
12. Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality.
Kempen JH; Newcomb CW; Washington TL; Foster CS; Sobrin L; Thorne JE; Jabs DA; Suhler EB; Rosenbaum JT; Sen HN; Levy-Clarke GA; Nussenblatt RB; Bhatt NP; Lowder CY; Goldstein DA; Leiderman YI; Acharya NR; Holland GN; Read RW; Dunn JP; Dreger KA; Artornsombudh P; Begum HA; Fitzgerald TD; Kothari S; Payal AR; Daniel E; Gangaputra SS; Kaçmaz RO; Liesegang TL; Pujari SS; Khachatryan N; Maghsoudlou A; Suga HK; Pak CM; Helzlsouer KJ; Buchanich JM;
Ophthalmology; 2023 Dec; 130(12):1258-1268. PubMed ID: 37499954
[TBL] [Abstract][Full Text] [Related]
13. Incidence of and risk factors for myelodysplastic syndrome in patients with rheumatologic diseases.
Kim YE; Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
Rheumatology (Oxford); 2024 May; 63(5):1305-1312. PubMed ID: 37498607
[TBL] [Abstract][Full Text] [Related]
14. Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis.
Adrianzen-Herrera D; Sparks AD; Singh R; Alejos-Castillo D; Batra A; Glushakow-Smith S; Pradhan K; Shastri A; Zakai NA
Blood Adv; 2023 Nov; 7(22):6913-6922. PubMed ID: 37729616
[TBL] [Abstract][Full Text] [Related]
15. Risk of cancer in relatives of patients with myelodysplastic neoplasia and acute leukemias.
Nitschke NJ; Rostgaard K; Andersen MK; Hjalgrim H; Grønbæk K
Cancer Epidemiol; 2024 Feb; 88():102523. PubMed ID: 38198910
[TBL] [Abstract][Full Text] [Related]
16. [Environmental and occupational risk factors for myelodysplastic syndrome].
Garnier R
Bull Cancer; 2023 Nov; 110(11):1116-1128. PubMed ID: 37419729
[TBL] [Abstract][Full Text] [Related]
17. Herpes Simplex Virus Encephalitis in Patients With Autoimmune Conditions or Exposure to Immunomodulatory Medications.
Tang A; Yoshida K; Lahey H; Wilcox DR; Guan H; Costenbader K; Solomon D; Miyawaki EK; Bhattacharyya S
Neurology; 2024 May; 102(10):e209297. PubMed ID: 38696733
[TBL] [Abstract][Full Text] [Related]
18. Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications.
Efficace F; Lo-Coco F
Haematologica; 2013 Jan; 98(1):7-9. PubMed ID: 23277592
[No Abstract] [Full Text] [Related]
19. Myeloid neoplasms post cytotoxic therapy: epidemiology, pathogenesis outcomes, prognostic factors, and treatment options.
Ma J; Wang Y
Ann Med; 2024 Dec; 56(1):2329132. PubMed ID: 38608646
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic radiography and adult acute myeloid leukaemia: an interview and medical chart review study.
Pogoda JM; Nichols PW; Ross RK; Stram DO; Thomas DC; Preston-Martin S
Br J Cancer; 2011 Apr; 104(9):1482-6. PubMed ID: 21522150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]